110 related articles for article (PubMed ID: 9721983)
1. Bradykinin metabolism in rat hind limbs.
Griswold JA; Baker CR; Little DT; Little GH; Behal FJ
Shock; 1998 Aug; 10(2):146-52. PubMed ID: 9721983
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin metabolism in perfused rat kidney.
Griswold JA; Baker CR; Little DT; Little GH; Behal FJ
Shock; 1999 May; 11(5):372-9. PubMed ID: 10353545
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin metabolism in the liver and lung of the rat.
Griswold JA; Beall CV; Baker CR; Little DT; Little GH; Behal FJ
J Surg Res; 1996 Nov; 66(1):12-20. PubMed ID: 8954825
[TBL] [Abstract][Full Text] [Related]
4. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ
Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602
[TBL] [Abstract][Full Text] [Related]
5. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Prechel MM; Orawski AT; Maggiora LL; Simmons WH
J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
[TBL] [Abstract][Full Text] [Related]
6. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
Oliveira EB; Martins AR; Camargo AC
Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
[TBL] [Abstract][Full Text] [Related]
7. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
Erşahin C; Simmons WH
J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin.
Ryan JW; Berryer P; Chung AY; Sheffy DH
J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881
[TBL] [Abstract][Full Text] [Related]
10. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.
Ahmad M; Zeitlin IJ; Parratt JR; Pitt AR
Arch Pharm Res; 2006 Mar; 29(3):241-8. PubMed ID: 16596998
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
12. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
[TBL] [Abstract][Full Text] [Related]
13. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of bradykinin by the rat coronary vascular bed.
Dumoulin MJ; Adam A; Blais C; Lamontagne D
Cardiovasc Res; 1998 Apr; 38(1):229-36. PubMed ID: 9683926
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
Ward PE; Chow A; Drapeau G
Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of vasoactive polypeptides by perfused rat liver.
Borges DR; Limãos EA; Prado JL; Camargo AC
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):33-40. PubMed ID: 1004640
[TBL] [Abstract][Full Text] [Related]
18. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
Orawski AT; Simmons WH
Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
[TBL] [Abstract][Full Text] [Related]
19. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.
Shima C; Majima M; Katori M
Jpn J Pharmacol; 1992 Oct; 60(2):111-9. PubMed ID: 1479739
[TBL] [Abstract][Full Text] [Related]
20. Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin).
Morinelli TA; Meier GP; Webb JG; Jaffa AA; Privitera PJ; Margolius HS
Int Immunopharmacol; 2002 Dec; 2(13-14):1995-2003. PubMed ID: 12489813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
